Table 6

Survival estimates according to prophylactic glutamine use
Survival Glutamine (+) Glutamine (−) P-value
(N=56) (N=48)
Overall
Median (months) 21.4 20.4 0.23
2-year (%) 37.0 34.2
3-year (%) 27.8 22.8
Locoregional progression free
Median (months) 11.3 14.2 0.11
2-year (%) 18.7 16.4
3-year (%) 18.7 16.4
Progression free
Median (months) 10.2 9.0 0.19
2-year (%) 17.5 14.6
3-year (%) 17.5 14.6

Topkan et al.

Topkan et al. BMC Cancer 2012 12:502   doi:10.1186/1471-2407-12-502

Open Data